Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Immatics Biotechnologies GmbH
Celldex Therapeutics
Roswell Park Cancer Institute
Duke University
Cancer Research UK
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Dana-Farber Cancer Institute